Cabaletta Bio Inc (CABA)
1.87
-0.39
(-17.26%)
USD |
NASDAQ |
Nov 21, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Cabaletta Bio Enterprise Value: -72.55M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | -72.55M |
| November 19, 2024 | -58.86M |
| November 18, 2024 | -51.04M |
| November 15, 2024 | -34.91M |
| November 14, 2024 | 1.744M |
| November 13, 2024 | 12.99M |
| November 12, 2024 | 27.16M |
| November 11, 2024 | 34.98M |
| November 08, 2024 | 36.45M |
| November 07, 2024 | 40.72M |
| November 06, 2024 | 44.14M |
| November 05, 2024 | 22.16M |
| November 04, 2024 | 12.39M |
| November 01, 2024 | -1.777M |
| October 31, 2024 | -9.593M |
| October 30, 2024 | 2.131M |
| October 29, 2024 | 22.16M |
| October 28, 2024 | 17.27M |
| October 25, 2024 | 7.993M |
| October 24, 2024 | 5.306M |
| October 23, 2024 | 13.86M |
| October 22, 2024 | 26.56M |
| October 21, 2024 | 37.79M |
| October 18, 2024 | 56.60M |
| October 17, 2024 | 53.91M |
| Date | Value |
|---|---|
| October 16, 2024 | 44.63M |
| October 15, 2024 | 28.51M |
| October 14, 2024 | 24.60M |
| October 11, 2024 | 22.65M |
| October 10, 2024 | 9.947M |
| October 09, 2024 | 19.23M |
| October 08, 2024 | 29.00M |
| October 07, 2024 | 12.88M |
| October 04, 2024 | 25.09M |
| October 03, 2024 | 27.53M |
| October 02, 2024 | 42.19M |
| October 01, 2024 | 43.65M |
| September 30, 2024 | 47.56M |
| September 27, 2024 | 4.870M |
| September 26, 2024 | -8.319M |
| September 25, 2024 | -10.27M |
| September 24, 2024 | -6.853M |
| September 23, 2024 | 10.24M |
| September 20, 2024 | 26.36M |
| September 19, 2024 | 26.36M |
| September 18, 2024 | 15.62M |
| September 17, 2024 | 1.451M |
| September 16, 2024 | -10.76M |
| September 13, 2024 | -2.457M |
| September 12, 2024 | -6.365M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-80.52M
Minimum
Jun 14 2022
935.85M
Maximum
Feb 08 2024
186.37M
Average
161.57M
Median
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 159.11B |
| NovaBay Pharmaceuticals Inc | 2.745M |
| Palatin Technologies Inc | 15.49M |
| iBio Inc | 9.932M |
| Theriva Biologics Inc | -12.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.63M |
| Total Expenses (Quarterly) | 33.05M |
| EPS Diluted (Quarterly) | -0.62 |
| Earnings Yield | -114.6% |